A seasoned scientific leader with over 25 years of experience in the life science sector. Experienced in preclinical, translational, and analytical development of biologics, with deep expertise in IND-enabling studies involving toxicology, pharmacology, immunology and pathogenesis.
His track record includes leading the non-clinical development in vaccinology and therapeutics that have targeted:
- Influenza
- Dengue
- Zika
- Chikungunya
- SARS-CoV-2
- HFMD (EV71, CVA6 & 16)
He has extensive experience in developing in-vivo models and supports global CRO oversight & management, non-clinical IND strategy (PK/PD, biodistribution & DART studies), assay development, including immunoassays, NAB assays, cell-based assays and molecular assays. He also supports regulatory submissions for study design & data presentation.
Subash is a Doctor of Veterinary Medicine (DVM) and holds M.A. & Ph.D. in Microbiology & Immunology and is a certified Project Management Professional (PMP).
